Clinical Trials Directory

Trials / Completed

CompletedNCT06875687

Prostaglandin Analog Eyelash Serum and Ocular Surface Health: A Prospective Study

Effects of a Prostaglandin Analog-Based Eyelash Serum on Ocular Surface Integrity and Tear Film Stability: A Prospective Interventional Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
19 (actual)
Sponsor
University of Seville · Academic / Other
Sex
Female
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

This prospective interventional study investigates the effects of a prostaglandin analog-based eyelash serum on ocular surface integrity, tear film stability, and eyelash growth over six weeks. Nineteen healthy female participants applied the serum daily, with clinical assessments performed at baseline and post-treatment. The study adhered to ethical guidelines, and parameters such as tear film stability, tear volume, ocular hyperemia, and eyelash characteristics were evaluated.

Conditions

Interventions

TypeNameDescription
OTHERProstaglandin Analog-Based Eyelash SerumThis intervention consists of a prostaglandin analog-based eyelash serum applied once daily to the upper eyelid margin for six weeks. The serum contains dechloro dihydroxy difluoro ethylcloprostenolamide (DDDE), a prostaglandin analog known to promote eyelash growth. The formulation also includes panax ginseng root extract, urtica dioica extract, panthenol, niacinamide, and biotinoyl tripeptide-1, which contribute to hair follicle nourishment. The study evaluates its effects on ocular surface integrity, tear film stability, and eyelash growth.

Timeline

Start date
2025-01-15
Primary completion
2025-02-28
Completion
2025-02-28
First posted
2025-03-13
Last updated
2025-03-28

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06875687. Inclusion in this directory is not an endorsement.